Last reviewed · How we verify

NCT05530304: triple_branch

Outcome of a Triple Inner Branched Aortic Arch Stentgraft. A Prospective, Multicenter Registry.

Recruiting now Last updated 13 September 2023
What this trial tests

trial testing Triple inner branched arch stentgraft in Aortic Arch in 30 participants. Currently enrolling.

Timeline
9 February 2023
Primary endpoint
31 December 2026
31 March 2027

Quick facts

Lead sponsorUniversity Hospital Muenster
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment30
Start date9 February 2023
Primary completion31 December 2026
Estimated completion31 March 2027
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Muenster

Who can join

Eligibility, any sex, with Aortic Arch or Aortic Arch Aneurysm. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Outcome of a triple inner branched aortic arch stentgraft. A prospective, mulitcenter registry.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Aortic Arch

Currently open trials in the same condition.

Other University Hospital Muenster trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05530304.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing